| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033346270 |
| P356 | DOI | 10.1038/SJ.GT.3302281 |
| P698 | PubMed publication ID | 15141160 |
| P5875 | ResearchGate publication ID | 8565208 |
| P50 | author | Georges Vassaux | Q39997171 |
| P2093 | author name string | Lemoine NR | |
| Goussard S | |||
| Grillot-Courvalin C | |||
| Radford KJ | |||
| Jezzard S | |||
| Critchley RJ | |||
| P2860 | cites work | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
| Combination bacteriolytic therapy for the treatment of experimental tumors | Q24555050 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Bacteria as gene delivery vectors for mammalian cells | Q33744891 | ||
| Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules | Q33853004 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors | Q33923778 | ||
| Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? | Q33986125 | ||
| The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
| pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. | Q36380649 | ||
| Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy | Q37660477 | ||
| A dicistronic construct allows easy detection of human CFTR expression from YAC DNA in human cells. | Q39721424 | ||
| A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. | Q40697734 | ||
| Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. | Q40959661 | ||
| Beta 1 integrin-dependent and -independent polymerization of fibronectin | Q41254786 | ||
| Functional gene transfer from intracellular bacteria to mammalian cells | Q41484997 | ||
| Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells | Q41511934 | ||
| Characterization of the upp gene encoding uracil phosphoribosyltransferase of Escherichia coli K12. | Q42602220 | ||
| Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts | Q42771254 | ||
| Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. | Q43630497 | ||
| Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis | Q43918986 | ||
| Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation | Q45879277 | ||
| Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo | Q47992263 | ||
| Salmonella pathogenicity island-2 and anticancer activity in mice | Q50107502 | ||
| Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells. | Q54524661 | ||
| An innate sense of danger | Q56672999 | ||
| Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil | Q64380268 | ||
| Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase | Q74088875 | ||
| P433 | issue | 15 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 1224-1233 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Potential therapeutic applications of recombinant, invasive E. coli | |
| P478 | volume | 11 |
| Q37288950 | A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer |
| Q39996938 | A new transgenic mouse line to image chemically induced p53 activation in vivo. |
| Q37050540 | Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli |
| Q33281558 | Biochemical and structural characterization of mammalian-like purine nucleoside phosphorylase from the Archaeon Pyrococcus furiosus |
| Q46945028 | Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury |
| Q33775617 | Direct injection of functional single-domain antibodies from E. coli into human cells |
| Q41458834 | Engineered E. coli delivers therapeutic genes to the colonic mucosa. |
| Q39588838 | Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells |
| Q61808391 | Evaluation of Transfection Efficiency in Skeletal Muscle Using Nano/Microbubbles and Ultrasound |
| Q37078471 | Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella |
| Q39094446 | Gene Therapeutic Approaches to Overcome ABCB1-Mediated Drug Resistance |
| Q35596405 | Gene transfer: Bax to the future for cancer therapy |
| Q30802898 | High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion |
| Q34120110 | Hybrid biosynthetic gene therapy vector development and dual engineering capacity |
| Q28543432 | Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy |
| Q41062293 | Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches. |
| Q54425194 | Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. |
| Q35992258 | Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis |
| Q35329206 | Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment |
| Q41458677 | Observation of the intracellular behavior of recombinant Yersinia pseudotuberculosis invasin protein |
| Q30453356 | Patterning bacterial communities on epithelial cells |
| Q39086898 | Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity |
| Q33327560 | Prodrug converting enzyme gene delivery by L. monocytogenes |
| Q35708412 | Proliferation behavior of E. coli in a three-dimensional in vitro tumor model |
| Q41454449 | Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination |
| Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
| Q39329973 | Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes |
| Q45877992 | Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. |
| Q39336979 | TBK1 does not play a role in the control of in vitro Burkholderia pseudomallei growth |
| Q33691013 | The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene |
| Q36955901 | Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors |
| Q38473938 | Treating cancer with infection: a review on bacterial cancer therapy |
| Q47422296 | Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors |